Combination oral agent and insulin therapy for type 2 diabetes mellitus.

Abstract

Type 2 diabetes is a chronic metabolic disorder that results from defects in both insulin secretion and insulin action. Over time, there is progressive beta-cell failure. Combination oral and insulin therapy aims at treating both the defects in underlying pathophysiology and replacing insulin once beta-cell failure has occurred. Combination therapy is… (More)

Topics

Cite this paper

@article{Passaro2001CombinationOA, title={Combination oral agent and insulin therapy for type 2 diabetes mellitus.}, author={Maureen D Passaro and Rebecca Ratner}, journal={Current diabetes reports}, year={2001}, volume={1 2}, pages={106-11} }